Today

Agents

Chat

Arena

Discover

More

App

Rapport Therapeutics CEO Abraham Ceesay sells 2,210 shares worth $92,999.37 - RAPP News | Rallies

Rapport Therapeutics CEO Abraham Ceesay sells 2,210 shares worth $92,999.37

RAPP•2026-07-29

CEO share sale reported in filing

Rapport Therapeutics CEO Abraham Ceesay sold 2,210 common shares on July 27, 2026.

Sales were priced at USD 42.11 and USD 42.74.

Direct holdings fell to 537,607 shares following the transactions.

The form also reported 81,729 shares held by the Ceesay Family Irrevocable Trust and 20,729 shares held by the Dorothy Ceesay Irrevocable Trust.

Related News

Addentax Group prices 250,000-share private placement at $4.8 each for $1.2 million

ATXG•2026-07-29

Easterly Government Properties declares quarterly dividend of $0.45 a share

DEA•2026-07-29

Vista Gold Q2 EPS USD -0.02

Sources

S

Rapport Therapeutics CEO Abraham Ceesay sells 2,210 shares worth $92,999.37

Sec

2026-07-29

Beta Bionics Q2 FY26 net loss widens 39% to $23.4 million; net sales climb 38% to $32 million

BBNX•2026-07-29

WEX CFO Narula to speak at Bank of America SMID Cap Executive Insights event

WEX•2026-07-29